30 • Forbidden Cures and Underground Medicine
Source, which at that time was a new company devoted to advancing the
world of natural medicine.
Their devotion to Beljanski’s mission shows in their work. Take the
materials that make up the Prostabel formula. They’re painstakingly harvested
from the far reaches of the earth—Pao pereira comes from the Amazon Rain
Forest, and Rauwolfia vomitoria is gathered from the root of a tropical African
tree. They’re then purified and rigorously tested. And then there’s the research
they’ve sought out to prove the value of these miraculous herbs.
Cancer cell growth cut by 90%
in less than a day
The work of Mirko Beljanski—and Natural Source’s continuation of that
work—caught the eye of Dr. Aaron Katz, a leader in the field of natural medi-
cine and men’s health. His research home base is Columbia University, where
the studies on the ingredients in Prostabel have taken place.
Dr. Katz’s research on the formula started with a meeting with Beljanski’s
daughter Sylvie. She was confident in her father’s work, and wanted to share
it with the world. Dr. Katz was hopeful, but told Sylvie there were no guar-
antees. And the team at Natural Source knew they were taking a big risk in
offering Pao pereria and Rauwolfia vomitoria up for trials—Dr. Katz’s team
was going to report the truth no matter the outcome.
But it turned out that Sylvie and Natural Source had nothing to worry
about. The power of these two herbs was revealed almost immediately. In fact,
members of Dr. Katz’s team have called Pao pereira and Rauwolfia vomitoria
the “most promising candidates to date” when it comes to fighting prostate
and bladder cancer.
A major human trial is underway at Columbia’s Department of Urology,
and preliminary results are very promising. Especially considering the results
Dr. Katz has already seen in men taking Prostabel. A trial of 30 men with
high PSA readings and a negative biopsy (meaning they don’t have cancer yet)
showed that Protabel significantly lowered PSA over the course of a year.
And the men taking Prostabel had other good news to report—a dramatic
improvement in urinary symptoms. They had better streams and better flow
rates, and weren’t getting up as often at night. There was one more unusual
bit to report from that trial, too—not one person dropped out because of side
effects, because nobody experienced any.
When it comes to cancer, there haven’t been any human trials completed
yet, but in vitro and animal trials are incredibly promising.